Jimenez Kristine, Lang Michaela
Universitätsklinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich.
Wien Med Wochenschr. 2016 Oct;166(13-14):402-410. doi: 10.1007/s10354-016-0495-5. Epub 2016 Aug 26.
Anemia affects a fourth of the global population, with iron deficiency remaining the primary cause. It is associated with diminished work capacity, fatigue, impaired cognitive function, and can negatively impact the course of diseases like chronic heart failure or chronic kidney disease. Treatment options include oral and intravenous iron; however, conditions such as inflammatory bowel disease, celiac disease, or autoimmune gastritis can diminish the efficacy of oral iron. Timely recognition of iron deficiency anemia and administration of appropriate therapy not only improves quality of life, but also reduces the need for blood transfusions. Proper selection of iron-deficient patients for whom further diagnostic testing is necessary facilitates identification of underlying diseases that require specific treatment, and avoids unnecessary invasive testing.
贫血影响着全球四分之一的人口，缺铁仍然是主要原因。它与工作能力下降、疲劳、认知功能受损有关，并且会对慢性心力衰竭或慢性肾病等疾病的病程产生负面影响。治疗选择包括口服铁剂和静脉注射铁剂；然而，诸如炎症性肠病、乳糜泻或自身免疫性胃炎等病症会降低口服铁剂的疗效。及时识别缺铁性贫血并给予适当治疗不仅能提高生活质量，还能减少输血需求。为需要进一步诊断测试的缺铁患者进行恰当选择，有助于识别需要特定治疗的潜在疾病，并避免不必要的侵入性检查。
